Hinge Health, Inc. Class A Common Stock (HNGE)

Revenue surged 52% as operating margins expanded 1,300 basis points year over year.

Hinge Health (NYSE:HNGE) reported third-quarter revenue growth of 52% year over year and raised its full-year outlook, as the digital musculoskeletal care company cited higher member engagement, client additions and improved operating leverage. Revenue for the third quarter was $235 million, compar

Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update.

Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026.

Oscar Health, Hinge Health, and Insmed post strong earnings and revenue growth in 2026, with analysts projecting further upside despite sector risks like Medicaid cuts and drug pricing pressure.

Leslie maintains a $2.6 million stake after the 4% reduction.

Hinge Health's stock has surged in 2026 on strong Q2 earnings and expansion into migraine and GI care, but its rich valuation leaves little room for execution missteps.

Yield improvements and member engagement drove 53% revenue growth in the quarter.

As AI infrastructure spending tops $725 billion for 2026, TradeSmith's Keith Kaplan points to Lemonade, AppLovin and Hinge Health as application-layer stocks turning AI into actual profit.

Hinge Health (NYSE:HNGE) reported second-quarter 2026 revenue of $213 million, up 53% from a year earlier and above the company’s prior guidance range of $200 million to $202 million. The digital healthcare company also raised its full-year revenue and operating-income outlook, citing durable improv

Hinge Health, Inc. (NYSE: HNGE) today announced that it has signed a definitive agreement to acquire Cylinder Health, Inc, a leader in virtual-first digestive healthcare, for $105 million in cash consideration. With this acquisition, Hinge Health intends to launch an integrated Gastrointestinal (GI) Care Program to complement its existing Musculoskeletal (MSK) and Migraine Care Programs.

Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2026 and provided a business update.

Hinge Health, Inc. (NYSE: HNGE) announced today the publication of a new study that showed a significant reduction in the risk of falls and emergency room (ER) visits among adults aged 65+.

Insider liquidated 426,000 shares at $90.21 following a 101% one-year rally, yet retains 12.2 million derivative securities for continued exposure.

Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended June 30, 2026, after the U.S. financial markets close on Tuesday, August 4, 2026.

Hinge Health, a digital musculoskeletal care provider, reported a notable insider sale amid strong one-year share price gains.

Hinge Health, Inc. (NYSE: HNGE) today announced the expansion of HingeSelect to include orthopedic surgery, now delivering care across the entire musculoskeletal (MSK) journey. Members begin with first-line treatment and orthopedic evaluation to determine whether surgery is appropriate. When surgery is needed, Hinge Health supports the journey from pre-op through recovery, connecting members to high-quality surgeons through the HingeSelect network.

Tomorrow, June 10, Hinge Health, Inc. (NYSE: HNGE) will host its inaugural Investor Day at Movement - the company’s annual conference that brings employers, health plans, consultants, providers and clinical experts together to discuss the evolution of healthcare. The Investor Day presentations will begin at 1:00 pm CT and the session will be available via webcast on Hinge Health’s investor relations website. During the session, investors will hear directly from leaders across the company about the company’s strategy and future opportunities.

Hinge Health, Inc. (NYSE: HNGE) today announced the results of the most comprehensive medical claims analysis of its digital musculoskeletal (MSK) solution, demonstrating an average cost savings of $2,941 per member per year using its chronic MSK program and a 3.0x ROI for employers and health plans.

Hinge Health (NYSE:HNGE) reported first-quarter 2026 results that topped its prior outlook and raised its full-year guidance, citing stronger-than-expected member engagement, growth in eligible lives and continued operating leverage from artificial intelligence and automation. Co-Founder and CEO Da

Hinge Health (HNGE) Q1 2026 Earnings Transcript

Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026.

Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for people living with migraine, MSK pain, or both.